E. Genbrugge

Associations of anticoagulant use with outcome in newly diagnosed glioblastoma.

R. Stupp, M. Weller, T. Gorlia, 2018, European journal of cancer.

MGMT Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials

M. Gilbert, R. Stupp, M. Weller, 2018, Clinical Cancer Research.

Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.

M. J. van den Bent, M. Weller, T. Gorlia, 2019, Neuro-oncology.

Insights into the association of ACEIs/ARBs use and COVID-19 prognosis: a multistate modelling study of nationwide hospital surveillance data from Belgium

J. Peñalvo, M. V. D. van der Sande, D. Van Beckhoven, 2021, BMJ Open.

Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis

R. Stupp, M. Weller, T. Gorlia, 2020, International journal of cancer.